27 July 2023>: Clinical Research
Factors Associated with Severe Adenovirus Pneumonia in Children: A Retrospective Study from Guangzhou, China (2017–2019)
Yan Hong ABCDEF , Qiang Wang BCE , Yongling Song BCE , Guangming Liu BCDE , Jun Shen ACDEG*DOI: 10.12659/MSM.939578
Med Sci Monit 2023; 29:e939578
Table 6 The treatment and outcomes of patients between mild and severe group.
Variable | Total | Mild group | Severe group | P value | |
---|---|---|---|---|---|
Steroid administration (%) | 0 | 124 (71.68) | 103 (88.03) | 21 (37.50) | 0.000 |
1 | 49 (28.32) | 14 (11.97) | 35 (62.50) | ||
Gamma globulin therapy (%) | 0 | 167 (96.53) | 114 (97.44) | 53 (94.64) | 0.390 |
1 | 6 (3.47) | 3 (2.56) | 3 (5.36) | ||
Antibiotics (%) | 0 | 45 (26.01) | 39 (33.33) | 6 (10.71) | 0.002 |
1 | 128 (73.99) | 78 (66.67) | 50 (89.29) | ||
Plasma transfusion (%) | 0 | 161 (93.06) | 115 (98.29) | 46 (82.14) | 0.000 |
1 | 12 (6.94) | 2 (1.71) | 10 (17.86) | ||
Albumin treatment (%) | 0 | 145 (84.3) | 114 (97.44) | 31 (55.36) | 0.000 |
1 | 27 (15.7) | 2 (1.71) | 25 (44.64) | ||
Vasoactive drugs usage (%) | 0 | 165 (97.06) | 117 (100.00) | 49 (87.50) | 0.000 |
1 | 5 (2.94) | 0 (0.00) | 7 (12.50) | ||
Acetylcysteine solution inhalation (%) | 0 | 101 (58.72) | 83 (70.94) | 19 (33.93) | 0.000 |
1 | 71 (41.28) | 34 (29.06) | 37 (66.07) | ||
Oxygen supply (%) | 0 | 136 (79.07) | 116 (99.15) | 21 (37.50) | 0.000 |
1 | 36 (20.93) | 1 (0.85) | 35 (62.50) | ||
Bronchoscopy (%) | 0 | 119 (72.12) | 100 (85.47) | 23 (41.07) | 0.000 |
1 | 46 (27.88) | 17 (14.53) | 33 (58.93) | ||
Admission to ICU (%) | 0 | 169 (97.69) | 116 (99.15) | 53 (94,64) | 1.000 |
1 | 4 (2.31) | 1 (0.85) | 3 (5.36) | ||
Prognosis after treatment (%) | 0 | 13 (7.51) | 1 (0.85) | 12 (21.43) | 0.000 |
1 | 160 (92.49) | 116 (99.15) | 44 (78.57) |